Fetal Erythroblastosis, also known as erythroblastosis, fetal, is related to blood group incompatibility and neonatal jaundice. An important gene associated with Fetal Erythroblastosis is POLR1C (RNA Polymerase I And III Subunit C), and among its related pathways/superpathways are Metabolism and Drug ADME. The drugs gamma-Globulins and Immunoglobulin G have been mentioned in the context of this disorder. Affiliated tissues include placenta and heart, and related phenotype is homeostasis/metabolism.